UNCY icon

Unicycive Therapeutics
UNCY

Overview Fund Activity

29 hedge funds and large institutions have $34.5M invested in Unicycive Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
Vivo Capital
California
$6.54M
2
Vanguard Group
Vanguard Group
Pennsylvania
$697K
3
Geode Capital Management
Geode Capital Management
Massachusetts
$333K
4
ACP
Acuta Capital Partners
California
$1.35M
5
Northern Trust
Northern Trust
Illinois
$62K

Top Sellers

1
ACM
Altium Capital Management
New York
$0
2
NCM
Nantahala Capital Management
Connecticut
$5.4M
3
Walleye Capital
Walleye Capital
New York
$2.35M
4
SCM
Silverarc Capital Management
Massachusetts
$1.39M
5
XT
XTX Topco
Cayman Islands
$70.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$246 +$11 +2 +5%
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$106 -$12 -2 -10%
BWL
28
Bogart Wealth LLC
Virginia
$34 – – –
SS
29
SBI Securities
Japan
$14 -$9 -2 -40%
ACM
30
Altium Capital Management
New York
– -$1.17M -147,300 Closed
HAIM
31
Hunter Associates Investment Management
Pennsylvania
– -$12K -1,500 Closed
TRCT
32
Tower Research Capital (TRC)
New York
– -$8.65K -1,089 Closed
FI
33
FWG Investments
Kentucky
– -$8.12K -1,022 Closed
SWA
34
SOA Wealth Advisors
New York
– -$794 -100 Closed
Citigroup
35
Citigroup
New York
– -$466 -59 Closed
1
2